2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Welcome Please Check in for continuing

2nd Annual Prostate Cancer ForumSeptember 22, 2012 • Charles H. Wright Museum of African American History • Detroit, MI

Welcome

Please• Check in for continuing education credits &

complete the evaluation upon completion of the Symposium

• Turn all cell phones/pagers to vibrate• Refreshments provided throughout the

program




Thank You• Jeffrey Albaugh, PhD,APRN,

CUCNS• Robert Chapman, MD• Carol Christner• Terry Foster• Jerry Lee Hardy• Elisabeth Heath, MD• Joe Ezell • Bester King• Kristen Kingzett, MD

• Steven Lucas, MD• Jordan Maier, MD• Ruthie Maples, MSW• Michael Poole• Isaac Powell, MD• Roderick Samuels• Virgil Simons• Kathryn Smolinski• Jeffrey Triest, MD• Ulka Vaishampayan, MD


Thank You to Our Sponsors• Abbott• Astellas• Dendreon• Endo Pharmaceuticals• Ferring Pharmaceutical• Janssen Biotec• Medivation• Millennium• Sanofi-Aventis• Veridex


Virgil Simons, MPA, MBAFounder & PresidentThe Prostate Net


Health Initiatives in the Era of Healthcare Reform:

Can We Afford the Care We Need

Prostate Cancer in America

• $11 Billion Spent on Care• U. S. Population Is Aging• New Therapeutics Come at a High Price• Quality Adjusted Life Year (QALY) Standards• Value$ Spent: Who Determines


Do We Pay to Die or

Invest to Live


Carol ChristnerDirector, Government RelationsKarmanos Cancer Institute


Politics and Prostates

Oral Chemotherapy Access

Oral Chemotherapies

• Biualutamide (Casodex ®),Flutamide (Eulexin®),Niutamide (Nilandron®)

• Oral chemotherapies work by targeting and attacking only cancer cells.

• 10% of available chemotherapies• 25 – 35% of medications in the oncology

development pipeline.

Intravenous vs Oral Chemotherapy Insurance Coverage

1. Intravenous/Injected– Typically covered under “Medical Benefit”– Office visit co-pay– No fee for the drug

2. Oral– Typically covered under “Pharmacy Benefit”– Highest tier of plan’s cost-sharing system– Co-pay can be percentage of drug cost

Michigan Senate Bills 540-541 and House Bills 5132-5133

• Bills do NOT: – Mandate coverage of oral or IV chemotherapy.– Require health plans to have a pharmacy benefit.

• Bills DO: – Require that oral and IV chemotherapies be

covered in the same manner.– Ensure that patients have real access to the

medications deemed most appropriate by their physician.


Rodrick SamuelsNational Salon and Barber EducatorProfile Barber Institute/The Andis Company

Who in the Prostate is Rodrick Samuels?

Cutting Out Prostate Cancer with your host…Rodrick Samuels?

• National Educator• Philanthropist• School Owner• Master Barber• Mentor• Business Developer• Lover of Health

Prostates

Social Media is social…STALK ME!

Improving doctor-patient communication

Doctors need to hear patients desires for quality of life

Patients need to understand what the doctor is telling them

Treatment and Life after Cancer

Doctors… Patients…

2011 PROSTATE CANCER STATISTICS SUMMARY

240,890 New Cases

33,720 Deaths a Year

92 Deaths a Day

4 Deaths an Hour

Barber Shops Impact the Community

• The place to be• Place of security and

comfort • Cultural institution • An avenue to

disseminate health education information

THE ROI…• Information conduit for the

medical community• Increased service for the

client community• Enhanced leadership

profile for the Med Ctr.• Better service interaction

between communities• Increased Med Ctr.

traffic/revenue/market share

• Increased Clinical Trial accrual

• Barber satisfaction in being an agent for change

22ndnd Annual Prostate Cancer Annual Prostate Cancer SymposiumSymposium

Patient Doctor CommunicationPatient Doctor CommunicationBuilding Effective Disease Building Effective Disease

Management DialoguesManagement Dialogues

9/22/129/22/12

Prostate Cancer at HFHProstate Cancer at HFH

Stage at Stage at DiagnosisDiagnosis– I: 13.6%I: 13.6%– II: 71.9%II: 71.9%– III: 5.9%III: 5.9%– IV: 5.2%IV: 5.2%– UKN: 3.4%UKN: 3.4%

Stage at Stage at DiagnosisDiagnosis– I: 13.7%I: 13.7%– II: 66.2%II: 66.2%– III: 4.4%III: 4.4%– IV: 10.5%IV: 10.5%– UKN: 5.2%UKN: 5.2%

Communication OpportunitiesCommunication Opportunities

In the Lay CommunityIn the Lay Community– Within the FamilyWithin the Family– Through church or place for religious Through church or place for religious

gatheringgathering– Education through the workplaceEducation through the workplace

Primary CarePrimary Care– Screening decisionsScreening decisions

Specialty CareSpecialty Care– Diagnostic, Staging, and treatment decisionsDiagnostic, Staging, and treatment decisions

One ApproachOne Approach

QQuestion uestion PPrompt rompt LList (QPL) Developmentist (QPL) Development– Lay Community inputLay Community input– Physician reviewPhysician review

Randomized Prospective testingRandomized Prospective testing– Usual care v QPL v QPL + CounselingUsual care v QPL v QPL + Counseling– Videotaping and analyzing Dr. / Patient Videotaping and analyzing Dr. / Patient

discussion during decision making visitsdiscussion during decision making visits

Documents

2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Welcome Please Check in for continuing